Mesenchymal Stem Cell-Based Therapy As a New Therapeutic Approach for Acute Inflammation Publisher Pubmed



Abdolmohammadi K¹ ; Mahmoudi T² ; Alimohammadi M³ ; Tahmasebi S³ ; Zavvar M⁵ ; Hashemi SM^{3, 4}
Source: Life Sciences Published:2023

Abstract

Acute inflammatory diseases such as acute colitis, kidney injury, liver failure, lung injury, myocardial infarction, pancreatitis, septic shock, and spinal cord injury are significant causes of death worldwide. Despite advances in the understanding of its pathophysiology, there are many restrictions in the treatment of these diseases, and new therapeutic approaches are required. Mesenchymal stem cell-based therapy due to immunomodulatory and regenerative properties is a promising candidate for acute inflammatory disease management. Based on preclinical results, mesenchymal stem cells and their-derived secretome improved immunological and clinical parameters. Furthermore, many clinical trials of acute kidney, liver, lung, myocardial, and spinal cord injury have yielded promising results. In this review, we try to provide a comprehensive view of mesenchymal stem cell-based therapy in acute inflammatory diseases as a new treatment approach. © 2022 Elsevier Inc.